At the news
? BEARISHIMPACT 5/10 CLUSTER filed Sep 15, 2026 at 17:23 ET
Cytokinetics CEO Robert Blum sold $7.3M in open-market shares (97,926 shares at $69.33 and 7,500 at $73.44) alongside director Robert Landry selling $147K and EVP Fady Malik selling $264K, totaling ~$7.7M in insider sales over a 7-day window. The CEO's sales coincide with derivative exercises and gifts, but the open-market sales are material at ~0.08% of the $9.6B market cap.
- CEO Robert Blum sold 97,926 shares open-market at $69.33 for $6.79M on 2026-09-15
- CEO Blum also sold 7,500 shares at $73.44 for $551K on 2026-09-14
- EVP R&D Fady Malik sold 3,500 shares at $75.46 for $264K on 2026-09-08
- Director Robert Landry sold 1,000 shares at $72.13 and 1,000 at $74.66, total $147K
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access